FDA Grants Breakthrough Device Designation for Roche’s Elecsys GDF-15 Assay
The in vitro diagnostic immunoassay is intended for measurement of growth differentiation factor-15 in cachectic patients with solid tumors for treatment with Pfizer’s investigational drug PF-06946860.
Read More